CLINICAL TRIALS PROFILE FOR NADOLOL AND BENDROFLUMETHIAZIDE
✉ Email this page to a colleague
All Clinical Trials for NADOLOL AND BENDROFLUMETHIAZIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00647660 ↗ | Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2006-07-01 | The objective of this study was to investigate the bioequivalence of Mylan's nadolol/bendroflumethiazide 80 mg/5 mg tablets to King's Corzide® 80 mg/5 mg tablets following a single, oral 80 mg/5 mg (1 x 80 mg/5 mg) dose administered under fasting conditions. |
| NCT00648297 ↗ | Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2006-08-01 | The objective of this study was to investigate the bioequivalence of Mylan's nadolol/bendroflumethiazide 80 mg/5 mg tablets to King's Corzide® 80 mg/5 mg tablets following a single, oral 80 mg/5 mg (1 x 80 mg/5 mg) dose administered under fed conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NADOLOL AND BENDROFLUMETHIAZIDE
Condition Name
Clinical Trial Locations for NADOLOL AND BENDROFLUMETHIAZIDE
Trials by Country
Clinical Trial Progress for NADOLOL AND BENDROFLUMETHIAZIDE
Clinical Trial Phase
Clinical Trial Sponsors for NADOLOL AND BENDROFLUMETHIAZIDE
Sponsor Name
